Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-21

Clinical Trial Update: Efficacy Comparison of Tamoxifen and Tamoxifen With Antioxidants on Semen Quality of Male With Idiopathic Infertility [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing tamoxifen alone versus tamoxifen with antioxidants for semen quality in men with idiopathic infertility.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamoxifen (tamoxifen)

Snippet

Sponsor: Sharif Medical Research Center | Conditions: Oligoasthenoteratozoospermia, Male Infertility | Phase 2 | Status: UNKNOWN